Concepedia

Gerardo Musuraca

GM

51

Publications

2.7K

Citations

26

H-Index

2003

Active since

Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Bologna

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Ospedale "Santa Maria delle Croci" di Ravenna

Gerardo Musuraca is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in medicine, oncology, and health sciences.

ORCID

Top concepts

Publications per year

2003–2024

51

Publications

51

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Paolo Ghia, Andrzej Pluta, Daniel Lysák et al. · Journal of Clinical Oncology · 2020 · 351 citations

Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Pier Luigi Zinzani, Gerardo Musuraca, Monica Tani et al. · Journal of Clinical Oncology · 2007 · 279 citations · Full text

Role of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma

Pier Luigi Zinzani, Vittorio Stefoni, Monica Tani et al. · Journal of Clinical Oncology · 2009 · 165 citations

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients

Pier Luigi Zinzani, Monica Tani, Stefano Fanti et al. · Annals of Oncology · 2006 · 149 citations

, , +8

Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi

Francesco Merli, Stefano Luminari, Alessandra Tucci et al. · Journal of Clinical Oncology · 2021 · 149 citations · Full text

, , +18

Rows per page

1–5 of 51